Skip to main content

ABI Releases TaqMan Assay Data to Public Database

NEW YORK (GenomeWeb News) - Applied Biosystems has released into the public domain the validation data for its TaqMan drug metabolism genotyping assays, the company said today.
The data, which was released through the Pharmacogenomics Knowledge Base, is aimed at helping researchers understand how genetic variation among individuals contributes to differences in reactions to drugs.
Researchers can use the data on validated genotyping assays available in PharmGKB to “expedite the design and execution of genetic studies correlating genotype to drug efficacy or toxicity,” said Teri Klein, director of the PharmGKB project at Stanford University.
Applied Biosystems also said studies show that its TaqMan assays provide higher accuracy than other methodologies in identifying variations in genes that code for drug metabolism enzymes.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.